Urine test for bladder cancer in people with blood in urine
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new urine test that looks for DNA changes to find bladder or urinary tract cancer in people who have blood in their urine. The goal is to see if this simple test can detect cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 99 years old.
- You have blood in your urine (either visible or seen under a microscope).
- You can provide a urine sample before any surgery.
- You agree to take part and sign a consent form.
- You do not have a current or past cancer diagnosis (except maybe skin cancer).
- You do not have a severe urinary infection causing sepsis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special urine testing approach can better identify and sort risk in people (especially veterans) who were referred to urology for blood in the urine. It may help doctors decide who needs more urgent follow-up and which next steps to take.
This trial checks whether a new lab test on urine can help sort out which people with small amounts of blood in the urine (microscopic hematuria) might have bladder cancer. It may help doctors evaluate symptoms more accurately and decide who needs further testing.
This study looks at a simple urine test to see if it can help tell who might have bladder cancer when there is invisible blood in the urine. It is for people over 40 who have had this finding recently.
This trial is testing a urine test called Bladder EpiCheck to see if it can help find bladder cancer in people who have blood in their urine. You would give a urine sample and then have a standard cystoscopy as part of your care.
This trial looks at how a urine DNA test may help find bladder cancer (or clues that it might be present), especially in people with symptoms or higher risk. You may be asked to provide urine and also complete standard tests like imaging, a cystoscopy, or pathology checks.
This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.
Hear when a new Hematuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.